Novel mRNA vaccines encoding Monkeypox virus proteins show promise in preclinical studies

Close up of chemical microscope and medical research equipment in scientific laboratory. Liquid examination tool with glass lens and blood samples in vacutainers on professional desk

In a recent study posted to the bioRxiv* preprint server, researchers in China demonstrated the efficacy of three messenger ribonucleic acid (mRNA) technology-based Monkeypox virus (MPXV) vaccines in combating a lethal Vaccinia virus (VACV) challenge in mice models.

Eating more foods with higher Food Compass scores lunked to better long-term health outcomes

Previous article

New family of adeno-associated viral vectors found to be better at delivering genetic cargo

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News